Andrew Ustianowski, MBBS

North Manchester General Hospital

Disclosure: Vir/GlaxoSmithKline (Advisor or Review Panel member)

Presentation(s):

• LB5 - PROVENT: Phase 3 Study of Efficacy and Safety of AZD7442 (Tixagevimab/Cilgavimab) for Pre-exposure Prophylaxis of COVID-19 in Adults

  Thursday, September 30, 2021
  6:15 PM – 6:30 PM EDT